About US
Contact us
-
Generic Reglan user can sue Pfizer for damagesIt's a state court ruling. It directly affects only one drugmaker. But the Alabama Supreme Court's decision to allow a patient to sue Pfizer ($PFE) for damages could ripple through the industry--and2013/1/15
-
Patients laud Lundbeck, Gilead, but give pharma's rep low marksPatients aren't happy with the pharma industry. A drumbeat of bad pharma news in 2012 took its toll on public opinion to the point where only one-third of patient groups gave drugmakers a thumbs-up.2013/1/15
-
India to hit Roche, BMS with compulsory licenses on 3 cancer drugsIndia is taking another swipe at Big Pharma. Three swipes, in fact: The government has started the process of granting three more compulsory licenses, this time on cancer treatments from Roche ($RHHB2013/1/14
-
Wockhardt receives approval for generic epilepsy tabletsWockhardt has announced the receipt of final approval for the marketing of a generic form of Lamotrigine, a form of medication which is used to treat epilepsy. The pharmaceutical and biotechnology2013/1/14
-
Lilly settles suit linking old miscarriage drug to breast cancerThe first court fight over the old miscarriage drug DES and alleged links to breast cancer didn't last long. On the second day of the trial, Eli Lilly ($LLY) settled with the four plaintiffs, who had2013/1/11
-
FDA orders dosage cuts on Sanofi's Ambien and its relativesWhat's one of the FDA's biggest worries about sleeping-pill safety? Hint: It's not your usual sort of adverse event. It's more like a bank shot off the human body than a hit to the body itself: Auto2013/1/11
-
Is rumored pharma target Bausch + Lomb aiming for an IPO instead?Big Pharma CEOs are throwing cold water on expectations for more medium-sized M&A this year. While analysts see promise for $10 billion deals, executives from Novartis ($NVS) to the newly indepen2013/1/10
-
Swiss insurer jumps into legal fight over Bayer's YasminBayer has another foe in its battle to defend the contraceptive pill Yasmin. Switzerland's biggest insurer, CSS, is backing a woman's claims against the German company, joining in her lawsuit that al2013/1/10
-
China hits Big Pharma meds with 15%-plus price cutsPharma's path to a big payoff in China is growing narrower and narrower. The government has just announced its fourth drug-price cut since 2011, with 400 meds subject to forced discounts. And on that2013/1/9
-
Ethris Announces Research Based Alliance on SNIM® Modified RNA with ShireEthris GmbH and Shire today announce the initiation of a research based alliance focused on the development and commercialization of novel RNA-based therapeutics. Many devastating human diseases2013/1/9